【レポートの概要(一部)】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Introduction
06.Disease Overview
06.1 Glaucoma
06.1.1 Understanding the Disease
06.1.2 Types of Glaucoma
06.1.3 Etiology
06.1.4 Signs and Symptoms
06.1.5 Diagnosis
06.1.6 Management
06.1.7 Epidemiology
06.2 Dry Eye Syndrome
06.2.1 Understanding the Disease
06.2.2 Types of Dry Eye Syndrome
06.2.3 Causes of Dry Eye Syndrome
06.2.4 Risk Factors of Dry Eye Syndrome
06.2.5 Signs and Symptoms
06.2.6 Diagnosis
06.2.7 Management
06.3 Diabetic Retinopathy
06.3.1 Understanding the Disease
06.3.2 Etiology
06.3.3 Diagnosis
06.3.4 Classification
06.3.5 Epidemiology
06.3.6 Management
06.4 RVO
06.4.1 Understanding the Disease
06.4.2 Types of RVO
06.4.3 Etiology
06.4.4 Diagnosis
06.4.5 Management
06.5 AMD
06.5.1 Understanding the Disease
06.5.2 Stages of AMD
06.5.3 Types of AMD
06.5.4 Etiology
06.5.5 Signs and Symptoms
06.5.6 Diagnosis
06.5.7 Management
06.6 Macular Edema
06.6.1 Understanding the Disease
06.6.2 Etiology
06.6.3 Diagnosis
06.6.4 Management
06.7 Economic Burden of Ophthalmic Diseases
07.Pipeline Analysis
07.1 Pipeline Portfolio: Glaucoma
07.1.1 Rhopressa
07.1.2 Roclatan
07.1.3 Trabodenoson
07.1.4 Lomerizine HCl
07.1.5 Y-39983
07.2 Pipeline Portfolio: Dry Eye Syndrome
07.2.1 Lifitegrast
07.2.2 OPC-12759E
07.2.3 EBI-005
07.3 Pipeline Portfolio: Diabetic Retinopathy
07.3.1 Squalamine
07.3.2 K-115-R/Ripasudil Hydrochloride Hydrate
07.4 Pipeline Portfolio: AMD
07.4.1 Anecortave Acetate (Suspension)
07.4.2 E10030
07.4.3 Abicipar
07.5 Pipeline Portfolio: RVO
07.5.1 TLC399
07.5.2 AGN208397
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09.Market Segmentation by Disease Type
09.1 Global Ophthalmic Therapeutics Market by Disease Type
09.2 Glaucoma
09.3 Dry Eye Syndrome
09.4 Retinal Disorders
09.4.1 Diabetic Retinopathy
09.4.2 Macular Edema
09.4.3 AMD
09.4.4 RVO
09.5 Global Glaucoma Therapeutics Market
09.5.1 Market Size and Forecast
09.6 Global AMD Therapeutics Market
09.6.1 Market Size and Forecast
09.7 Global Macular Edema Therapeutics Market
09.7.1 Market Size and Forecast
09.8 Global Dry Eye Syndrome Therapeutics Market
09.8.1 Market Size and Forecast
09.9 Global Diabetic Retinopathy Therapeutics Market
09.9.1 Market Size and Forecast
09.10 Global RVO Therapeutics Market
09.10.1 Market Size and Forecast
10.Market Segmentation by Route of Administration
10.1 Topical
10.2 Systemic
10.2.1 IV
10.2.2 Oral
10.3 Intravitreal
11.Market Segmentation by Molecule Type
11.1 Biologics
11.2 Small Molecules
12.Market Segmentation by Dosage Form
12.1 Solutions
12.2 Implants
12.3 Pills
13.Geographical Segmentation
13.1 Global Ophthalmic Therapeutics Market by Geography 2014-2019
14.Buying Criteria
15.Market Growth Drivers
16.Drivers and Their Impact
17.Market Challenges
18.Impact of Drivers and Challenges
19.Market Trends
20.Trends and Their Impact
21.Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Market Share Analysis 2014
21.2.1 Novartis
21.2.2 Actavis
21.2.3 F. Hoffmann-La Roche
21.2.4 Regeneron Pharmaceuticals
21.2.5 Bayer
21.2.6 Pfizer
21.2.7 Merck
21.3 Other and Future Prominent Vendors
22.Key Vendor Analysis
22.1 Actavis
22.1.1 Key Facts
22.1.2 Business Description
22.1.3 Business Segmentation
22.1.4 Business Segmentation by Revenue 2012 and 2013
22.1.5 Sales by Geography
22.1.6 Business Strategy
22.1.7 Key Information
22.1.8 SWOT Analysis
22.2 Bayer
22.2.1 Key Facts
22.2.2 Business Overview
22.2.3 Business Segmentation by Revenue 2014
22.2.4 Business Segmentation by Revenue 2013 and 2014
22.2.5 Geographical Segmentation by Revenue 2014
22.2.6 Business Strategy
22.2.7 Recent Developments
22.2.8 SWOT Analysis
22.3 F. Hoffmann-La Roche
22.3.1 Key Facts
22.3.2 Business Overview
22.3.3 Business Segmentation
22.3.4 Business Segmentation by Revenue 2012 and 2013
22.3.5 Sales by Geography
22.3.6 Business Strategy
22.3.7 Key Information
22.3.8 SWOT Analysis
22.4 Merck
22.4.1 Key Facts
22.4.2 Business Overview
22.4.3 Business Segmentation by Revenue 2013
22.4.4 Business Segmentation by Revenue 2012 and 2013
22.4.5 Sales by Geography
22.4.6 Business Strategy
22.4.7 Key Developments
22.4.8 SWOT Analysis
22.5 Novartis
22.5.1 Key Facts
22.5.2 Business Description
22.5.3 Business Segmentation
22.5.4 Revenue by Business Segmentation
22.5.5 Revenue Comparison 2012 and 2013
22.5.6 Sales by Geography
22.5.7 Business Strategy
22.5.8 Key Developments
22.5.9 SWOT Analysis
22.6 Pfizer
22.6.1 Key Facts
22.6.2 Business Overview
22.6.3 Business Segmentation by Revenue 2014
22.6.4 Business Segmentation by Revenue 2013 and 2014
22.6.5 Geographical Segmentation by Revenue 2014
22.6.6 Business Strategy
22.6.7 Key developments
22.6.8 SWOT Analysis
22.7 Regeneron Pharmaceuticals
22.7.1 Key Facts
22.7.2 Business Overview
22.7.3 Product Segmentation
22.7.4 Revenue Product Segmentation
22.7.5 Business Strategy
22.7.6 Key Information
22.7.7 SWOT Analysis
23.Other Reports in This Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Major Ophthalmic Conditions
Exhibit 3: Types of Glaucoma
Exhibit 4: Development of Diabetic Retinopathy
Exhibit 5: Classification of Diabetic Retinopathy
Exhibit 6: Types of RVO
Exhibit 7: Types of AMD
Exhibit 8: Global Ophthalmic Therapeutics Market 2014-2019 ($ millions)
Exhibit 9: Global Ophthalmic Therapeutics Market by Disease Type
Exhibit 10: Global Ophthalmic Therapeutics Market by Disease Type 2014
Exhibit 11: Global Glaucoma Therapeutics Market 2014-2019 ($ millions)
Exhibit 12: Key Takeaways: Global Glaucoma Therapeutics Market
Exhibit 13: Global AMD Therapeutics Market 2014-2019 ($ millions)
Exhibit 14: Key Takeaways: Global AMD Therapeutics Market
Exhibit 15: Global Macular Edema Therapeutics Market 2014-2019 ($ millions)
Exhibit 16: Key Takeaways: Global Macular Edema Therapeutics Market
Exhibit 17: Global Dry Eye Syndrome Therapeutics Market 2014-2019 ($ millions)
Exhibit 18: Key Takeaways: Global Dry Eye Syndrome Therapeutics Market
Exhibit 19: Global Diabetic Retinopathy Therapeutics Market 2014-2019 ($ millions)
Exhibit 20: Key Takeaways: Global Diabetic Retinopathy Therapeutics Market
Exhibit 21: Global RVO Therapeutics Market 2014-2019 ($ millions)
Exhibit 22: Key Takeaways: Global RVO Therapeutics Market
Exhibit 23: Global Ophthalmic Therapeutics Market: YoY Growth Rate and Revenue by Disease Type 2014-2019
Exhibit 24: Global Ophthalmic Therapeutics Market by Route of Administration
Exhibit 25: Global Ophthalmic Therapeutics Market by Molecule Type
Exhibit 26: Global Ophthalmic Therapeutics Market by Dosage Form
Exhibit 27: Global Ophthalmic Therapeutics Market by Geography 2014
Exhibit 28: Major Drivers of Global Ophthalmic Therapeutics Market
Exhibit 29: Major Challenges in Global Ophthalmic Therapeutics Market
Exhibit 30: Major Trends in Global Ophthalmic Therapeutics Market
Exhibit 31: Vendor Ranking 2014
Exhibit 32: Novartis: YoY Revenue and Growth Rate of Lucentis 2011-2014 ($ millions)
Exhibit 33: Actavis: YoY Revenue of Restasis 2012-2014 ($ millions)
Exhibit 34: Actavis: YoY Revenue of Lumigan 2012-2014 ($ millions)
Exhibit 35: Actavis: YoY Revenue of Alphagan, Alphagan P, and Combigan 2012-2014 ($ millions)
Exhibit 36: F. Hoffmann-La Roche: YoY Revenue and Growth Rate of Lucentis 2011-2014 ($ millions)
Exhibit 37: Regeneron Pharmaceuticals: YoY Revenue and Growth Rate of Eylea 2011-2014 ($ millions)
Exhibit 38: Bayer: YoY Revenue and Growth Rate of Eylea 2012-2014 ($ millions)
Exhibit 39: Pfizer: YoY Revenue and Growth Rate of Xalatan/Xalacom 2012-2014 ($ millions)
Exhibit 40: Actavis: Business Segmentation 2013
Exhibit 41: Actavis: Business Segmentation by Revenue 2012 and 2013 ($ millions)
Exhibit 42: Actavis: Sales by Geography ($ millions)
Exhibit 43: Bayer: Business Segmentation by Revenue 2014
Exhibit 44: Bayer: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 45: Bayer: Geographical Segmentation by Revenue 2014
Exhibit 46: Business Segmentation of F. Hoffmann-La Roche 2013
Exhibit 47: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 48: F. Hoffmann-La Roche: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 49: F. Hoffmann-La Roche: Sales by Geography 2013 (Diagnostics Division)
Exhibit 50: Merck: Business Segmentation by Revenue 2013
Exhibit 51: Merck: Business Segmentation by Revenue 2012 and 2013 ($ billions)
Exhibit 52: Merck: Sales by Geography 2013
Exhibit 53: Novartis: Business Segmentation
Exhibit 54: Novartis: Revenue by Business Segmentation 2013
Exhibit 55: Novartis AG: Revenue by Business Segmentation 2012 and 2013 ($ millions)
Exhibit 56: Novartis: Revenue by Geographical Segmentation 2013
Exhibit 57: Pfizer: Business Segmentation by Revenue 2014
Exhibit 58: Pfizer: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 59: Pfizer: Geographical Segmentation by Revenue 2014
Exhibit 60: Regeneron Pharmaceuticals: Product Segmentation
Exhibit 61: Regeneron Pharmaceuticals: Revenue Product Segmentation 2013
【レポート販売概要】
■ タイトル:眼科疾患治療薬の世界市場:緑内障、眼球乾燥症候群、網膜障害(糖尿病性網膜症、黄斑浮腫、RVO、AMD)■ 英文:Global Opthalmic Therapeutic Market 2015-2019
■ 発行日:2015年7月22日
■ 調査会社:Technavio
■ 商品コード:IRTNTR6492
■ 調査対象地域:グローバル
- ウォータースポーツ用品・装具の世界市場2016-2020:水中スポーツ用品、水上スポーツ用品About Water Sports Gear and Equipment Water sports gear and equipment include gear and equipment for any sports activity conducted in water, under water, and on water. The global water sports gear and equipment market is expected to grow at a CAGR of 5.37% during the forecast period. This growth can be attributed to the increasing interest for water tourism, including sailing and boating. Technavi …
- 農業用フィルムの世界市場:マルチング、グリーンハウス、サイレージ用途About Agricultural Films Agricultural films are new age films that are a component of modern farming technologies used to increase farm productivity. They are generally made from a variety of plastic resins such as PE, EVA, PVC, and PVOH. They offer a wide range of benefits in mulching, silage, and greenhouse applications such as controlling temperature and moisture of soil, elimination of weeds, …
- インダストリアルIoT(IIoT)の世界市場2016-2020About IIOT The use of IoT in manufacturing industries is called IIoT. It involves the integration of machinery with a network of software and sensors. IIoT plays a major role in improving profitability by reducing human intervention and eliminating risks associated with machine failures. The IIoT provides better insight regarding equipment used by companies, combining machines with analytics. IoT …
- 抗菌コーティングの世界市場分析:製品別(抗菌パウダーコーティング(銀、銅)、表面改質剤およびコーティング(大腸菌、リステリア、シュードモナス)、用途別(プラスチック、塗料・コーティング、パルプ・紙)、用途別、動向・動態、競争戦略と予測、2014-2025The global antimicrobial coatings market is expected to reach USD 8.43 billion by 2025, according to a new report by Grand View Research, Inc. Increasing concern among professional industry manufactures about cleaning and to prevent buildings against the growth of bacteria, mold and fungi are expected to drive the overall market growth. Recent food poisoning outbreaks coupled with high rates of ho …
- OMV Aktiengesellschaft:石油・ガスの開発・生産動向及びコスト分析– Q1, 2013OMV Aktiengesellschaft Oil & Gas Exploration and Production Operations and Cost Analysis – Q1, 2013 Summary OMV Aktiengesellschaft Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- 高機能合金の世界市場:非鉄合金、超合金About High-Performance Alloys High-performance alloys are a class of alloys that exhibit creep resistance at high temperatures and excellent mechanical strength. These alloys mainly consist copper, lead, titanium, rhenium, chromium cobalt, and nickel as base alloys. They exhibit properties such as resistance to corrosion, resistant to oxidation and sulfidation, heat resistance, and other related p …
- 自動車ステアリングの世界市場予測(~2021年):手動、HPS、EHPS、EPS、油圧ポンプ、ステアリングセンサ、ステアリングコラム、モータThe global steering market is projected to grow at a CAGR of 6.47% from 2016 to 2021, to reach a market size of USD 42.77 Billion by 2021. Stringent emission norms, the growing demand for driving comfort from consumers, and increasing vehicle production have fueled the growth of the steering market. The Asia-Oceania steering market is projected to grow at the highest CAGR during the forecast perio …
- グローバル菓子類市場におけるM&A動向(2014年3月)Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global confectionery market during March 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global confectionery market throughout the month. Additionally, the report provides an overview of all th …
- テレコムパワーソリューションの世界市場2019-2023About this market The growing adoption of hybrid telecom power systems will trigger the telecom power solutions market growth in the forthcoming years. The hybrid telecom power systems are witnessing a considerable rise in the adoption due to their several benefits over conventional systems. These systems offer reduced carbon footprint by the cell site, minimized operation and maintenance costs, a …
- 掘削流体および仕上げ流体の世界市場2015-2019About Drilling and Completion Fluids Drilling and completion fluids are fluids used in drilling activities to perform various functions. Drilling fluids, also referred to as drilling mud, is a composite fluid that is a mixture of chemical, water, and clays. Sometimes, oil is used instead of water to obtain desirable properties. These fluids, essentially used to cool and clean drill bits, reduce fr …
- 流量計の世界市場2019-2023About this market Advent of integrated DP flowmeter solution to drive growth in the market. The adoption of the solution is expected to increase during the forecast period due to its unique functions and benefits. Technavio’s analysts have predicted that the flowmeter market will register a CAGR of close to 6% by 2023. Market Overview Benefits associated with flowmeters The flowmeters are used in …
- 3Dマシンビジョンの世界市場予測(~2022)The 3D machine vision market is expected to be valued at USD 2.13 Billion by 2022, growing at a CAGR of 11.07% between 2017 and 2022. Some of the key factors driving the growth of this market are integration of 3D vision systems with robot controllers, rising demand for 3D object analyses in manufacturing applications, and increasing demand for non-industrial 3D machine vision systems. 3D machine …
- BYODセキュリティソリューションの世界市場:モバイルデバイス管理(MDM)、モバイルアプリケーション管理(MAM)About BYOD Security Enterprise mobility refers to accessing of corporate data by the employees using their personal devices. Enterprise mobility solutions serve the purpose of keeping the remotely working employees of an organization connected with the company and its data. The solution helps capture, manage, store, and transfer of corporate data through cloud-based services. An organization adopt …
- 二硫化炭素の世界市場Carbon Disulphide (CAS 75-15-0) Market Research Report 2014 presents comprehensive data on carbon disulphide markets globally and regionally (Europe, Asia, North America etc.) The report includes carbon disulphide description, covers its application areas and related patterns. It overviews carbon disulphide market, names carbon disulphide producers and indicates its suppliers. Besides, the report …
- 食品物流サービスの世界市場:トラック輸送、鉄道輸送、海上輸送、航空輸送About Food Logistics The Food industry uses logistics for the complete management of the way resources are acquired, stored, and moved to locations where they are required. The use of logistics helps the Food industry to have a continuous supply of durable and non-durable goods from various prominent suppliers and distributors across different locations. Sometimes companies might also choose to le …